⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Arimidex Observational: Reason for and Effect of Change From Tamoxifen

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Arimidex Observational: Reason for and Effect of Change From Tamoxifen

Official Title: Arimidex: Reason for and Effect of Change From Tamoxifen

Study ID: NCT00246961

Conditions

Breast Cancer

Interventions

Study Description

Brief Summary: The purpose of this study is to analyse the effect on quality of life after 3 months of treatment after changing adjuvant therapy from tamoxifen to Arimidex.

Detailed Description:

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: FEMALE

Healthy Volunteers: No

Locations

Research Site, 'S-Gravenhage, , Netherlands

Research Site, 's-Hertogenbosch, , Netherlands

Research Site, Alkmaar, , Netherlands

Research Site, Antwerpen, , Netherlands

Research Site, Apeldoorn, , Netherlands

Research Site, Bergen op Zoom, , Netherlands

Research Site, Boxmeer, , Netherlands

Research Site, Breda, , Netherlands

Research Site, Doetinchem, , Netherlands

Research SIte, Dordrecht, , Netherlands

Research Site, Ede, , Netherlands

Research Site, Eindhoven, , Netherlands

Research Site, Enschede, , Netherlands

Research Site, Geldrop, , Netherlands

Research Site, Groningen, , Netherlands

Research Site, Harderwijk, , Netherlands

Research Site, Helmond, , Netherlands

Research Site, Hoogeveen, , Netherlands

Research Site, Hoorn, , Netherlands

Research Site, Leiden, , Netherlands

Research Site, Oosterhout, , Netherlands

Research Site, Purmerend, , Netherlands

Research Site, Roermond, , Netherlands

Research Site, Roosendaal, , Netherlands

Research Site, Rotterdam, , Netherlands

Research Site, Schiedam, , Netherlands

Research Site, Terneuzen, , Netherlands

Research Site, Tiel, , Netherlands

Research Site, Venray, , Netherlands

Research Site, Vlissingen, , Netherlands

Research Site, Winterswijk, , Netherlands

Research Site, Zoetermeer, , Netherlands

Research Site, Zutphen, , Netherlands

Contact Details

Name: AstraZeneca The Netherlands Medical Director, MD

Affiliation: AstraZeneca

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: